RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Convergen

Convergen

Convergen develops targeted protein degradation therapies for diseases associated with pathological protein aggregates.

Latest funding

$15M Seed ·

Source: AllSci

Funding history ↓
Sectors: Biopharma, Biotechnology, Manufacturing, Pharmaceutical.
Stage: Seed.
Based in: Suzhou, China.
Last round: Aug 31, 2026 · 78 days ago.
On Recent Funding since: Oct 2, 2026.

Signals

Website registeredJan 13, 2021 (5 years old)

Funding rounds

DateRoundAmountLeadSource
Seed$15M—AllSci

Timeline

  1. Website created

Founders and team

Companies like Convergen

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/convergen (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy